Funder: National Institutes of Health

Due Dates: June 25, 2025 | October 25, 2025 | February 25, 2026 | June 25, 2026 | October 25, 2026 | February 25, 2027 | June 25, 2027 | October 25, 2027

Funding Amounts: Up to $225,000/year; max $450,000 direct costs over 3 years (no pilot trial) or $600,000 over 3 years (with pilot/feasibility trial); 3-year project period

Summary: Supports planning activities and feasibility studies to optimize the design and implementation of future cancer prevention and control clinical trials.

Key Information: Preliminary efficacy/effectiveness data for the intervention are required; non-domestic (foreign) organizations are eligible.